CEO SUMMARY: After Pharmacogenetics Diagnostic Laboratory LLC was audited by a Medicare Zone Program Integrity Contractor (ZPIC), it faced a $26 million repayment demand. The lab company appealed and asked for a redetermination, then filed for Chapter 11 bankruptcy protection. These developments should be a concern to all labs offering pharmacogenomic testing to Medicare patients. […]
$26 Million Recoupment from Medicare Audit Hammers Pharmacogenomic Lab
Lab hit with $26 million overpayment demand after ZPIC auditor denies 100% of sampled claims
- By Joseph Burns
- > From the Volume XXIV No. 1 - January 9, 2017 Issue
- Tags: aco, cap, clinical lab, clinical labs, dark report, diagnostic lab, diagnostic laboratories, diagnostic laboratory, diagnostic testing, exome sequencing, genomic testing, genomics, informatics, lab industry, lab test, laboratories, laboratory medicine, medical records, Medicare, Medicare Administrative Contractor, Medicare Part B, molecular diagnostic, molecular diagnostic test, molecular diagnostic testing, pathologists, Pathology group, pathology groups, patient record, pgxl, pgxl bankruptcy, pharmacogenetic, pharmacogenetics, pharmacogenetics diagnostic laboratory, pharmacogenomic tests, pharmacogenomics, the dark report
